首页 正文

Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia

{{output}}
Background: Chronic hepatitis B (CHB) remains a public health burden, with more than 257 million persons living with hepatitis B virus globally. Despite the availability of a safe and efficacious vaccine, access to immunization r... ...